Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Palvella Therapeutics Inc., 1 year.
Palvella Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Palvella Therapeutics Inc. | Open-market sale | −954 | $149.38 | $142,507 |
| Sep 15, 2026 | Palvella Therapeutics Inc. | Open-market sale | −263 | $150.40 | $39,556 |
| Sep 15, 2026 | Palvella Therapeutics Inc. | Open-market sale | −560 | $151.33 | $84,743 |
| Sep 14, 2026 | Palvella Therapeutics Inc. | Open-market sale | −5,632 | $151.46 | $853,037 |
| Sep 14, 2026 | Palvella Therapeutics Inc. | Open-market sale | −6,160 | $152.12 | $937,034 |
| Sep 14, 2026 | Palvella Therapeutics Inc. | Open-market sale | −1,560 | $153.10 | $238,834 |
| Sep 11, 2026 | Palvella Therapeutics Inc. | Open-market sale | −6,520 | $150.62 | $982,035 |
| Sep 11, 2026 | Palvella Therapeutics Inc. | Open-market sale | −4,577 | $151.72 | $694,403 |
| Sep 11, 2026 | Palvella Therapeutics Inc. | Open-market sale | −1,274 | $153.06 | $194,997 |
| Mar 30, 2026 | Palvella Therapeutics Inc. | Open-market purchase | +445 | $112.30 | $49,974 |
| Feb 27, 2026 | Palvella Therapeutics Inc. | Open-market purchase | +4,000 | $125.00 | $500,000 |
| Apr 9, 2025 | Palvella Therapeutics Inc. | Open-market purchase | +2,500 | $20.13 | $50,325 |
| Apr 9, 2025 | Palvella Therapeutics Inc. | Open-market purchase | +2,490 | $20.27 | $50,472 |
| Dec 18, 2024 | Palvella Therapeutics Inc. | Open-market purchase | +4,000 | $12.93 | $51,720 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.